SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000899866-20-000040
Filing Date
2020-05-06
Accepted
2020-05-06 06:54:20
Documents
16
Period of Report
2020-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-k05062020.htm   iXBRL 8-K 40355
2 EXHIBIT 99.1 erq12020.htm EX-99.1 429914
8 a2016earningsreleaseimagea32.jpg GRAPHIC 12335
  Complete submission text file 0000899866-20-000040.txt   662096

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alxn-20200422.xsd EX-101.SCH 4315
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alxn-20200422_cal.xml EX-101.CAL 639
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alxn-20200422_def.xml EX-101.DEF 1489
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alxn-20200422_lab.xml EX-101.LAB 26142
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alxn-20200422_pre.xml EX-101.PRE 13595
16 EXTRACTED XBRL INSTANCE DOCUMENT a8-k05062020_htm.xml XML 4269
Mailing Address 121 SEAPORT BOULEVARD BOSTON MA 02210
Business Address 121 SEAPORT BOULEVARD BOSTON MA 02210 4752302596
ALEXION PHARMACEUTICALS, INC. (Filer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27756 | Film No.: 20851065
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences